Supakarn Chamni
Impact in
- Biotechnology top 5%
- Marine Sponges and Natural Products
- Cancer Research top 10%
- Synthesis and Biological Activity
Papers in
-
- Synthesis and Biological Activity 21
- Pharmacology 20
- Microbial Natural Products and Biosynthesis 15
- Co-authors
- Pithi Chanvorachote (22 shared papers)Khanit Suwanborirux (19 shared papers)Naoki Saito (12 shared papers)Thanyada Rungrotmongkol (12 shared papers)Wanchai De‐Eknamkul (7 shared papers)Panupong Mahalapbutr (3 shared papers)Chatchai Chaotham (7 shared papers)Daniel Romo (3 shared papers)
In The Last Decade
Supakarn Chamni
50 papers receiving 723 citations
Peers
Comparison fields: 5 of 94
- Biotechnology 157
- Cancer Research 210
- Pharmacology 200
- Toxicology 36
- Pharmaceutical Science 45
Countries citing papers authored by Supakarn Chamni
This map shows the geographic impact of Supakarn Chamni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supakarn Chamni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supakarn Chamni more than expected).
Fields of papers citing papers by Supakarn Chamni
This network shows the impact of papers produced by Supakarn Chamni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supakarn Chamni. The network helps show where Supakarn Chamni may publish in the future.
Co-authors
The 25 scholars most cited alongside Supakarn Chamni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 62 | |
| 2 | 2020 | 37 | |
| 3 | 2018 | 31 | |
| 4 | Renieramycin M Sensitizes Anoikis-resistant H460 Lung Cancer Cells to Anoikis. | 2016 | 28 |
| 5 | 2022 | 25 | |
| 6 | 2019 | 25 | |
| 7 | 2017 | 24 | |
| 8 | 2019 | 23 | |
| 9 | 2019 | 23 | |
| 10 | 2019 | 22 | |
| 11 | 2016 | 22 | |
| 12 | 2013 | 21 | |
| 13 | 2014 | 20 | |
| 14 | 2018 | 20 | |
| 15 | 2017 | 19 | |
| 16 | 2023 | 19 | |
| 17 | 2022 | 19 | |
| 18 | 2024 | 18 | |
| 19 | 2008 | 17 | |
| 20 | 2021 | 16 |
About Supakarn Chamni
Supakarn Chamni is a scholar working on Cancer Research, Pharmacology, Biotechnology, Organic Chemistry and Molecular Biology, having authored 56 papers that have together received 726 indexed citations. Recurring topics across this work include Synthesis and Biological Activity (21 papers), Marine Sponges and Natural Products (17 papers), Microbial Natural Products and Biosynthesis (15 papers), Bioactive Compounds and Antitumor Agents (5 papers), Carbohydrate Chemistry and Synthesis (4 papers), Synthesis and Biological Evaluation (4 papers), Medicinal Plants and Neuroprotection (4 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Biotechnology (157 citations), Cancer Research (210 citations), Pharmacology (200 citations), Toxicology (36 citations) and Pharmaceutical Science (45 citations). Supakarn Chamni has collaborated with scholars based in Thailand, Japan and China. Frequent co-authors include Pithi Chanvorachote, Khanit Suwanborirux, Naoki Saito, Thanyada Rungrotmongkol, Wanchai De‐Eknamkul, Panupong Mahalapbutr, Chatchai Chaotham, Daniel Romo, Prasit Pavasant and Piyamas Sumrejkanchanakij. Their work appears in journals such as Marine Drugs, Scientific Reports, Molecules, Anticancer Research and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.